ES2301294A1 - Use of a mycosporin-type amino acid (m-gly) as an antioxidant - Google Patents
Use of a mycosporin-type amino acid (m-gly) as an antioxidant Download PDFInfo
- Publication number
- ES2301294A1 ES2301294A1 ES200502162A ES200502162A ES2301294A1 ES 2301294 A1 ES2301294 A1 ES 2301294A1 ES 200502162 A ES200502162 A ES 200502162A ES 200502162 A ES200502162 A ES 200502162A ES 2301294 A1 ES2301294 A1 ES 2301294A1
- Authority
- ES
- Spain
- Prior art keywords
- gly
- antioxidant
- amino acid
- type amino
- mycosporin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001413 amino acids Chemical class 0.000 title claims abstract description 17
- 230000003078 antioxidant effect Effects 0.000 title abstract description 34
- 239000003963 antioxidant agent Substances 0.000 title abstract description 27
- 241000028378 Lichina pygmaea Species 0.000 claims abstract description 18
- 238000002360 preparation method Methods 0.000 claims abstract description 8
- 230000002265 prevention Effects 0.000 claims abstract description 6
- 235000013376 functional food Nutrition 0.000 claims abstract description 5
- 239000002417 nutraceutical Substances 0.000 claims abstract description 5
- 235000021436 nutraceutical agent Nutrition 0.000 claims abstract description 5
- 239000000284 extract Substances 0.000 claims description 15
- 239000000047 product Substances 0.000 claims description 10
- 206010051246 Photodermatosis Diseases 0.000 claims description 6
- 230000008845 photoaging Effects 0.000 claims description 6
- 206010015150 Erythema Diseases 0.000 claims description 5
- VVTDHOIRNPCGTH-NSHDSACASA-N Mycosporine Chemical compound COC1=C(NC(CO)CO)C[C@@](O)(CO)CC1=O VVTDHOIRNPCGTH-NSHDSACASA-N 0.000 claims description 5
- 231100000321 erythema Toxicity 0.000 claims description 5
- 231100000589 photocarcinogenesis Toxicity 0.000 claims description 5
- 230000001225 therapeutic effect Effects 0.000 claims description 5
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 3
- 230000000699 topical effect Effects 0.000 claims description 2
- 239000002537 cosmetic Substances 0.000 claims 2
- 229940127557 pharmaceutical product Drugs 0.000 claims 2
- 239000000126 substance Substances 0.000 abstract description 13
- VVTDHOIRNPCGTH-UHFFFAOYSA-N Mycosporin 1 Natural products COC1=C(NC(CO)CO)CC(O)(CO)CC1=O VVTDHOIRNPCGTH-UHFFFAOYSA-N 0.000 abstract description 4
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 abstract description 4
- 230000036542 oxidative stress Effects 0.000 abstract description 2
- 101150018863 maa gene Proteins 0.000 description 25
- 235000006708 antioxidants Nutrition 0.000 description 24
- 150000003254 radicals Chemical class 0.000 description 24
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- 150000001875 compounds Chemical class 0.000 description 15
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 13
- 239000011648 beta-carotene Substances 0.000 description 13
- 235000013734 beta-carotene Nutrition 0.000 description 13
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 13
- 229960002747 betacarotene Drugs 0.000 description 13
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 13
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 238000000034 method Methods 0.000 description 12
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 12
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 11
- 230000009102 absorption Effects 0.000 description 10
- 238000010521 absorption reaction Methods 0.000 description 10
- -1 superoxide anions Chemical class 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 9
- 230000003647 oxidation Effects 0.000 description 9
- 238000007254 oxidation reaction Methods 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 7
- 229940087168 alpha tocopherol Drugs 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 230000003859 lipid peroxidation Effects 0.000 description 6
- 229940079877 pyrogallol Drugs 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 229960000984 tocofersolan Drugs 0.000 description 6
- 235000004835 α-tocopherol Nutrition 0.000 description 6
- 239000002076 α-tocopherol Substances 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- 241000195493 Cryptophyta Species 0.000 description 5
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 5
- 102000003992 Peroxidases Human genes 0.000 description 5
- 230000004075 alteration Effects 0.000 description 5
- 230000002255 enzymatic effect Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 235000020778 linoleic acid Nutrition 0.000 description 5
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 239000012429 reaction media Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 102000019197 Superoxide Dismutase Human genes 0.000 description 4
- 108010012715 Superoxide dismutase Proteins 0.000 description 4
- 241000208041 Veronica Species 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 230000001590 oxidative effect Effects 0.000 description 4
- 108040007629 peroxidase activity proteins Proteins 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- XZQILKYKJYHEHD-JTQLQIEISA-N 2-[[(5s)-5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohexen-1-yl]amino]acetic acid Chemical compound COC1=C(NCC(O)=O)C[C@@](O)(CO)CC1=O XZQILKYKJYHEHD-JTQLQIEISA-N 0.000 description 3
- 235000014653 Carica parviflora Nutrition 0.000 description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000004061 bleaching Methods 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 238000002845 discoloration Methods 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 229940126707 lipid peroxidation inhibitor Drugs 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- XZQILKYKJYHEHD-UHFFFAOYSA-N mycosporine glycine Natural products COC1=C(NCC(O)=O)CC(O)(CO)CC1=O XZQILKYKJYHEHD-UHFFFAOYSA-N 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 230000035882 stress Effects 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 241000242757 Anthozoa Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 102000016938 Catalase Human genes 0.000 description 2
- 108010053835 Catalase Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 102000006587 Glutathione peroxidase Human genes 0.000 description 2
- 108700016172 Glutathione peroxidases Proteins 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- KYCBIRYKYQCBFO-KPKJPENVSA-N Palythine Chemical compound COC1=C(N)CC(O)(CO)C\C1=[NH+]/CC([O-])=O KYCBIRYKYQCBFO-KPKJPENVSA-N 0.000 description 2
- 241000206609 Porphyra Species 0.000 description 2
- 241000206613 Pyropia yezoensis Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- HKZLNGQCWGVZIW-UHFFFAOYSA-N cyclohex-2-en-1-imine Chemical group N=C1CCCC=C1 HKZLNGQCWGVZIW-UHFFFAOYSA-N 0.000 description 2
- FWFSEYBSWVRWGL-UHFFFAOYSA-N cyclohex-2-enone Chemical compound O=C1CCCC=C1 FWFSEYBSWVRWGL-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000004042 decolorization Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 231100000673 dose–response relationship Toxicity 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- OUUQCZGPVNCOIJ-UHFFFAOYSA-N hydroperoxyl Chemical compound O[O] OUUQCZGPVNCOIJ-UHFFFAOYSA-N 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 238000004255 ion exchange chromatography Methods 0.000 description 2
- 230000002427 irreversible effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- AJGGWXHQTXRTPE-SNVBAGLBSA-N palythine Natural products COC1=C(C[C@@](O)(CO)CC1=N)NCC(=O)O AJGGWXHQTXRTPE-SNVBAGLBSA-N 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 230000003711 photoprotective effect Effects 0.000 description 2
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 2
- VIZAVBQHHMQOQF-KKUJBODISA-N porphyra-334 Chemical compound COC1=C(NCC(O)=O)CC(O)(CO)C\C1=N\[C@H]([C@H](C)O)C(O)=O VIZAVBQHHMQOQF-KKUJBODISA-N 0.000 description 2
- VIZAVBQHHMQOQF-UHFFFAOYSA-N porphyra-334 Natural products COC1=C(CC(O)(CO)C/C/1=NC(C(C)O)C(=O)O)NCC(=O)O VIZAVBQHHMQOQF-UHFFFAOYSA-N 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000002390 rotary evaporation Methods 0.000 description 2
- 230000009919 sequestration Effects 0.000 description 2
- WXEQFJUHQIGKNG-MZNRBSSJSA-N shinorine Chemical compound COC1=C(C[C@@](O)(CO)C\C1=N/[C@@H](CO)C(O)=O)NCC(O)=O WXEQFJUHQIGKNG-MZNRBSSJSA-N 0.000 description 2
- WXEQFJUHQIGKNG-UHFFFAOYSA-N shinorine Natural products COC1=C(CC(O)(CO)C/C/1=NC(CO)C(=O)O)NCC(=O)O WXEQFJUHQIGKNG-UHFFFAOYSA-N 0.000 description 2
- 238000002798 spectrophotometry method Methods 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- HWSJJSITUUMTSO-UHFFFAOYSA-N 2-[[5-hydroxy-5-(hydroxymethyl)-3-(1-hydroxypropan-2-ylamino)-2-methoxycyclohex-2-en-1-ylidene]amino]acetic acid Chemical compound COC1=C(NC(C)CO)CC(O)(CO)CC1=NCC(O)=O HWSJJSITUUMTSO-UHFFFAOYSA-N 0.000 description 1
- MBPQVWGCNCNOQG-UHFFFAOYSA-N 2-aminocyclohex-2-en-1-one Chemical class NC1=CCCCC1=O MBPQVWGCNCNOQG-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241001661607 Bostrychia scorpioides Species 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 241000192703 Chlorogloeopsis Species 0.000 description 1
- 241000243321 Cnidaria Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241001428241 Gelidium sesquipedale Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 241001428248 Gymnogongrus Species 0.000 description 1
- 241000028366 Lichina Species 0.000 description 1
- 241001147489 Mastocarpus stellatus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000206754 Palmaria palmata Species 0.000 description 1
- 108700020962 Peroxidase Proteins 0.000 description 1
- 241000434565 Platygyra ryukyuensis Species 0.000 description 1
- 241000321455 Plectropomus leopardus Species 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 241001491795 Pyropia leucosticta Species 0.000 description 1
- 241000277331 Salmonidae Species 0.000 description 1
- 241000490569 Stylophora pistillata Species 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 125000000746 allylic group Chemical group 0.000 description 1
- 150000001414 amino alcohols Chemical class 0.000 description 1
- 230000006851 antioxidant defense Effects 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000006701 autoxidation reaction Methods 0.000 description 1
- 150000001579 beta-carotenes Chemical class 0.000 description 1
- 239000003181 biological factor Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000001723 carbon free-radicals Chemical class 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 239000013626 chemical specie Substances 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003574 free electron Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 150000002432 hydroperoxides Chemical class 0.000 description 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 1
- 238000000099 in vitro assay Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 150000008040 ionic compounds Chemical class 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- SUBFIBLJQMMKBK-UHFFFAOYSA-K iron(3+);trithiocyanate Chemical compound [Fe+3].[S-]C#N.[S-]C#N.[S-]C#N SUBFIBLJQMMKBK-UHFFFAOYSA-K 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 238000003367 kinetic assay Methods 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 230000000065 osmolyte Effects 0.000 description 1
- NKJVQFFOGWSVTJ-AMIZOPFISA-N palythinol Natural products COC1=C(C[C@](O)(CO)CC1=N[C@H](C)CO)NCC(=O)O NKJVQFFOGWSVTJ-AMIZOPFISA-N 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 229960003330 pentetic acid Drugs 0.000 description 1
- 229940097156 peroxyl Drugs 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000000243 photosynthetic effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000027272 reproductive process Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000036561 sun exposure Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 230000008646 thermal stress Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 229910001428 transition metal ion Inorganic materials 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- OMPMQQQHTAPTHR-UHFFFAOYSA-N usujirene Natural products COC1=C(CC(O)(CO)C/C/1=NC=C/C)NCC(=O)O OMPMQQQHTAPTHR-UHFFFAOYSA-N 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/09—Lichens
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Birds (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
Description
Uso de aminoácido tipo micosporina (M-gly) en productos para prevención y tratamiento de eritema actínico, fotocarcinogénesis y fotoenvejecimiento.Use of mycosporine type amino acid (M-gly) in products for prevention and treatment of actinic erythema, photocarcinogenesis and photoaging.
La presente invención se encuadra en el sector biotecnológico y describe el potencial uso de un aminoácido tipo micosporina, concretamente de M-gly aislado del liquen marino Lichyna pygmaea, además de su posible aplicación en preparados farmacéuticos, nutraceúticos, o alimentos funcionales, entre otros, para la prevención y tratamiento terapéutico de eritema actínico, fotocarcinogénesis y fotoenvejecimiento.The present invention is part of the biotechnology sector and describes the potential use of a mycosporin-like amino acid, specifically of M-gly isolated from Lichyna pygmaea marine lichen, in addition to its possible application in pharmaceutical, nutraceutical, or functional food preparations, among others, for the prevention and therapeutic treatment of actinic erythema, photocarcinogenesis and photoaging.
La radiación ultravioleta es uno de factores biológicos que limitan la supervivencia, fisiología y crecimiento de muchos organismos. Algunos de los múltiples efectos dañinos de la radiación UV incluye la alteración de moléculas de ADN y proteínas, inactivación de enzimas y a la formación de radicales libres, los cuales atacan a membranas celulares y otras moléculas diana alterando su funcionalidad. Todos los organismos aerobios disponen de una gran variedad de sistemas de defensa antioxidante tanto enzimáticos como no enzimáticos que se coordinan cooperativamente y protegen al organismo de los riesgos que conlleva el estrés oxidativo. Entre ellos destacan las actividades enzimáticas de la superóxido dismutasa (SOD), glutatión peroxidasa (GPX) y catalasa (CAT); además del ácido ascórbico (vitamina C), \alpha-tocoferol (vitamina E), glutatión (GSH), \beta-caroteno, vitamina A, flavonoides y ácidos fenólicos entre otros.Ultraviolet radiation is one of factors biological factors that limit the survival, physiology and growth of Many organisms Some of the multiple harmful effects of UV radiation includes the alteration of DNA molecules and proteins, enzyme inactivation and free radical formation, the which attack cell membranes and other target molecules altering its functionality. All aerobic organisms have of a wide variety of antioxidant defense systems both Enzymatic as non-enzymatic that cooperatively coordinate and protect the body from the risks of stress oxidative Among them, the enzymatic activities of the superoxide dismutase (SOD), glutathione peroxidase (GPX) and catalase (CAT); in addition to ascorbic acid (vitamin C), α-tocopherol (vitamin E), glutathione (GSH), β-carotene, vitamin A, flavonoids and acids Phenolic among others.
Se entiende por radical libre a cualquier especie química que contiene uno o más electrones desapareados en sus orbitales externos de manera que un compuesto puede convertirse en radical libre captando o perdiendo un electrón. Aunque existen radicales libres de muy distinta naturaleza, son las especies que derivan de la molécula de oxígeno (ROS) las más abundantes en los organismos aerobios destacando productos de la ruptura o la excitación del O_{2} como el oxígeno singlete ^{1}O_{2} y especies de oxígeno que están parcialmente reducidas como el radical hidroxilo (OH\bullet), aniones superóxido (O_{2}^{-}) y peróxido de hidrógeno (H_{2}O_{2}). Estas moléculas inestables recorren el organismo tomando electrones con lo que recuperan su estabilidad electroquímica, esto las hace muy peligrosas porque para conseguirlo atacan moléculas estables. Una vez que el radical libre ha conseguido tomar el electrón que necesita para emparejar su electrón libre, la otra molécula se convierte a su vez en un radical libre, iniciándose así un ciclo destructivo para nuestras células.Free radical is understood as any chemical species that contains one or more missing electrons in its external orbitals so that a compound can become in free radical capturing or losing an electron. Although they exist free radicals of very different nature, are the species that derive from the oxygen molecule (ROS) the most abundant in aerobic organisms highlighting breakdown products or the excitation of O2 as singlet oxygen1O2 and oxygen species that are partially reduced as the hydroxyl radical (OH •), superoxide anions (O 2 -) and hydrogen peroxide (H2O2). These molecules unstable travel the body taking electrons with what they recover their electrochemical stability, this makes them very dangerous because to achieve this attack stable molecules. A once the free radical has managed to take the electron that you need to pair your free electron, the other molecule will turn in turn into a free radical, thus initiating a cycle destructive to our cells.
Los radicales libres dan lugar a alteraciones
importantes en moléculas como ADN, lípidos y proteínas, alterando
gravemente el ciclo y la funcionalidad celular. El ADN puede sufrir
pérdida de bases así como la ruptura de una o de ambas hebras del
material genético, alteraciones que pueden traducirse en mutaciones
irreversibles. Muchas proteínas son capaces de absorber una gran
cantidad de oxidaciones sin que aparentemente se vea afectada su
función. Sin embargo, es indudable que las consecuencias de las
alteraciones en algunas funciones, por ejemplo, la recepción y
transmisión de señales, el transporte de iones, la duplicación y
reparación del ADN, las respuestas a condiciones de tensión y el
metabolismo energético, la transcripción y traducción pueden ser
críticas para la célula. Los daños producidos por el OH\bullet y
el ^{1}O_{2} son irreversibles y en términos generales marcan
las proteínas para su degradación. Las membranas celulares también
pueden resultar seriamente dañadas en situación de estrés oxidativo
ya que fosfolípidos que tienen ácidos grasos con varios dobles
enlaces son muy susceptibles a la oxidación por pérdida de un
hidrógeno (alílico). Una vez generado el radical carbono en un
ácido graso, éste reacciona con el oxígeno molecular formando un
radical peroxilo. El radical peroxilo puede tomar un hidrógeno
alílico a otro metileno con lo cual se propaga la reacción. Los
hidroperóxidos, que son compuestos estables, si entran en contacto
con iones metálicos de transición producirán más radicales libres
que iniciarán y propagarán otras reacciones en cadena. Así, las
membranas resultan seriamente dañadas y por tanto su funcionalidad
se ve
alterada.Free radicals give rise to important alterations in molecules such as DNA, lipids and proteins, seriously altering the cycle and cellular functionality. The DNA can suffer loss of bases as well as the rupture of one or both strands of the genetic material, alterations that can result in irreversible mutations. Many proteins are capable of absorbing a large amount of oxidation without apparently affecting their function. However, there is no doubt that the consequences of alterations in some functions, for example, the reception and transmission of signals, the transport of ions, the duplication and repair of DNA, the responses to stress conditions and energy metabolism, transcription and translation can be critical for the cell. The damage caused by the OH and 1 O 2 are irreversible and generally mark the proteins for degradation. Cell membranes can also be seriously damaged in oxidative stress because phospholipids that have fatty acids with several double bonds are very susceptible to oxidation due to the loss of a hydrogen (allyl). Once the carbon radical is generated in a fatty acid, it reacts with molecular oxygen forming a peroxyl radical. The peroxyl radical can take an allylic hydrogen to another methylene whereby the reaction is propagated. Hydroperoxides, which are stable compounds, if they come into contact with transition metal ions will produce more free radicals that will initiate and propagate other chain reactions. Thus, the membranes are seriously damaged and therefore their functionality is seen
altered
Los radicales libres se asocian con un amplio rango de patologías y enfermedades como el Alzheimer o el Parkinson y afecciones relacionadas con la exposición solar como la aparición de cataratas, fotoenvejecimiento, episodios inflamatorios y neoplasias. También son los responsables de la oxidación de las grasas de los alimentos, que es la forma de deterioro más importante después de las alteraciones producidas por microorganismos. Con la oxidación, aparecen olores y sabores a rancio, se altera el color y la textura, y desciende el valor nutritivo al perderse algunas vitaminas y ácidos grasos poliinsaturados. Además, los productos formados en la oxidación pueden llegar a ser nocivos para la salud.Free radicals are associated with a broad range of pathologies and diseases such as Alzheimer's or Parkinson's and conditions related to sun exposure such as the appearance of cataracts, photoaging, inflammatory episodes and neoplasms They are also responsible for the oxidation of food fats, which is the most deteriorating form important after the alterations produced by microorganisms With oxidation, odors and flavors appear stale, the color and texture are altered, and the value drops nutritious when missing some vitamins and fatty acids polyunsaturated In addition, products formed in oxidation They can become harmful to health.
Los aminoácidos tipo micosporina están
constituidos por un anillo de ciclohexenona o de ciclohexenimina,
conjugado con un sustituyente nitrogenado de un aminoácido o su
aminoalcohol que actúa como cromóforo permitiendo la absorción de
determinada radiación de onda corta. Los metabolitos que se aíslan
en hongos presentan un rango de absorción entre 310 y 320 nm y
poseen anillos de ciclohexenona exclusivamente, conociéndoseles por
el nombre de micosporinas en referencia a su origen. Por el
contrario, los metabolitos que se aislan de organismos marinos y
algas contienen anillos de ciclohexenimina, con absorciones máximas
entre 310 y 360 nm y se les conoce con el nombre de aminoácidos
tipo micosporina ó MAAs. Aún así, la
mycosporine-glycine (M-gly) y la
mycosporine taurine son aminociclohexenonas aisladas de organismos
marinos. En la actualidad hay descritas 13 micosporinas distintas en
hongos y 23 MAAs en organismos marinos. Son moléculas pequeñas, con
pesos moleculares que rondan los 330 Da y presentan una alta
fotoestabilidad. Se comportan como moléculas anfóteras, similares a
los aminoácidos, de manera que presentan cargas positivas y
negativas en la misma molécula. Muestran características
físico-químicas propias de compuestos iónicos por
ejemplo alto punto de efusión y alta solubilidad en
agua.Mycosporin-type amino acids consist of a cyclohexenone or cyclohexenimine ring, conjugated with a nitrogenous substituent of an amino acid or its amino alcohol that acts as a chromophore allowing the absorption of certain shortwave radiation. The metabolites that are isolated in fungi have an absorption range between 310 and 320 nm and have cyclohexenone rings exclusively, being known by the name of mycosporins in reference to their origin. On the contrary, the metabolites that are isolated from marine organisms and algae contain cyclohexenimine rings, with maximum absorptions between 310 and 360 nm and are known as mycosporine-type amino acids or MAAs . Still, mycosporine-glycine (M-gly) and mycosporine taurine are aminocyclohexenones isolated from marine organisms. There are currently 13 different mycosporins described in fungi and 23 MAAs in marine organisms. They are small molecules, with molecular weights around 330 Da and have high photostability. They behave like amphoteric molecules, similar to amino acids, so that they have positive and negative charges on the same molecule. They show physicochemical characteristics of ionic compounds, for example, high effusion point and high solubility in
Water.
Son muchas las funciones que se les ha atribuido a estas moléculas en el organismo: desde osmolito orgánico en comunidades cianobacterianas Chlorogloeopsis, pigmentos accesorios fotosintéticos o precursores de estos, a moléculas determinantes en procesos reproductivos de algunas especies de peces, sin embargo es el papel fotoprotector frente a la radiación UV el más aceptado y documentado ya que al parecer actúan protegiendo parcialmente a los componentes celulares y procesos fisiológicos. Un número de trabajos han evaluado este tipo de moléculas por sus actividad como fotoprotectores de uso tópico vehiculizando extractos naturales con un alto porcentaje de MAAs y viendo su FPS y su potencial fotoprotector en células vegetales, queratinocitos humanos, etc. (Patente US 6787147; Patente WO 02/39974; Patente WO 03/020236). También se han publicado trabajos que hacen referencia a las propiedades antioxidativas de extractos obtenidos de algas y corales.There are many functions that have been attributed to these molecules in the organism: from organic osmolyte in Chlorogloeopsis cyanobacterial communities, photosynthetic accessory pigments or precursors of these, to determining molecules in reproductive processes of some species of fish, however it is the photoprotective role against UV radiation the most accepted and documented since apparently they act partially protecting cellular components and physiological processes. A number of studies have evaluated these types of molecules for their activity as topical photoprotectors, vehiculating natural extracts with a high percentage of MAAs and seeing their SPF and their photoprotective potential in plant cells, human keratinocytes, etc. (US Patent 6787147; WO 02/39974; WO 03/020236). Works have also been published that refer to the antioxidant properties of extracts obtained from algae and corals.
Dunlap y Yamamoto en 1995 (Comp. Biochem. Physiol. 112: 105-114) apuntaron a una posible actividad antioxidante de mycosporine-glycine mediante ensayos in vitro de peroxidación lipídica (método de la fosfatidilcolina) a partir de extractos de organismos marinos que contenían MAAs, mientras que otras iminoMAAs como porphyra 334, shinorine, palythine, asterine 330 y palythinol se mostraban oxidativamente robustas y no participaban en reacciones de oxidación-reducción. No obstante, como se ha indicado, dichos ensayos fueron realizados con extractos algales que contenían además de MAAs un alto porcentaje de otros componentes celulares como polisacáridos, enzimas, etc., por lo que no es posible afirmar firmemente la actividad antioxidante de mycosporine-glycine (o M-gly) en base a dicho trabajo.Dunlap and Yamamoto in 1995 (Comp. Biochem. Physiol. 112: 105-114) pointed to a possible antioxidant activity of mycosporine-glycine by in vitro assays of lipid peroxidation (phosphatidylcholine method) from extracts of marine organisms containing MAAs, while other iminoMAAs such as porphyra 334, shinorine, palythine, asterine 330 and palythinol were oxidatively robust and did not participate in oxidation-reduction reactions. However, as indicated, these tests were carried out with algal extracts that, in addition to MAAs, contained a high percentage of other cellular components such as polysaccharides, enzymes, etc., so it is not possible to firmly affirm the antioxidant activity of mycosporine-glycine (or M-gly) based on that work.
Nakayama y colaboradores en 1999 (J. Am. Oil
Chem. Soc., 76: 649-653) aislaron un nuevo
aminoácido tipo micosporina del alga roja Porphyra yezoensis
llamado usujilene, ya identificado en Palmaria palmata pero
no en ninguna especie de Porphyra. Sus resultados indicaban
que tal MAA mostraba actividad antioxidante frente a la autoxidación
del ácido linoleico (Métodos del ácido tiobarbitúrico y tiocianato
férrico), donando determinados hidrógenos a radicales lipídicos
LOO- y dando lugar a moléculas de MAAs estabilizadas por resonancia
al igual que el
\alpha-tocoferol.Nakayama et al. In 1999 (J. Am. Oil Chem. Soc., 76: 649-653) isolated a new mycosporin-like amino acid from the red algae Porphyra yezoensis called usujilene, already identified in Palmaria palmata but not in any species of Porphyra . Their results indicated that such MAA showed antioxidant activity against the autoxidation of linoleic acid (Thiobarbituric acid and ferric thiocyanate methods), donating certain hydrogens to LOO-lipid radicals and giving rise to resonance stabilized MAA molecules as well as
α-tocopherol.
Suh y colaboradores en 2003 (Photochem. Photobiol. 78: 109-113) sugieren también la función antioxidante de la M-gly, pero probablemente actuando junto con otros MAAs activos. La M-gly, entre otros, podría jugar un importante papel participando en la eliminación de O_{2}^{-} generado por sistemas fotosintetizadores endógenos.Suh et al. In 2003 (Photochem. Photobiol 78: 109-113) also suggest the function M-gly antioxidant, but probably acting together with other active MAAs. The M-gly, among others, could play an important role participating in the O_ {2} ^ {}} system-generated removal endogenous photosynthesizers.
Yakovleva y colaboradores en 2004 (Comp. Biochem. Physiol., 139: 721-739 examinaron la importancia de la M-gly como antioxidante funcional frente a estrés térmico en dos corales, Platygyra ryukyuensis y Stylophora pistillata, en base a la correlación entre el grado de susceptibilidad y la concentración endógena de M-gly.Yakovleva et al. In 2004 (Comp. Biochem. Physiol., 139: 721-739 examined the importance of M-gly as a functional antioxidant against thermal stress in two corals, Platygyra ryukyuensis and Stylophora pistillata , based on the correlation between degree of susceptibility and endogenous concentration of M-gly.
También la patente US2004228875 hace referencia a las propiedades antioxidativas de extractos obtenidos a partir de algas del género Porphyra, aunque sin concluir sobre el posible papel jugado por MAAs.Also the patent US2004228875 refers to the antioxidant properties of extracts obtained from algae of the genus Porphyra , although without concluding on the possible role played by MAAs.
Publicaciones más recientes analizan las propiedades antioxidativas de extractos obtenidos a partir de algas pero sin concretar la participación de MAAs (Yuan y colaboradores, 2005, Food Chem. Toxicol., 43: 1073-1081; Kuda y colaboradores, 2005, J. Food Compos. Anal., 18: 625-633).More recent publications analyze the antioxidant properties of extracts obtained from algae but without specifying the participation of MAAs (Yuan et al., 2005, Food Chem. Toxicol., 43: 1073-1081; Kuda and collaborators, 2005, J. Food Compos. Anal., 18: 625-633).
Se puede concluir, por tanto, que el papel antioxidante de los iminoMAAs como tales, es decir, purificados o aislados en un alto grado de pureza, no se conoce bien, como tampoco su comportamiento a nivel de secuestro de radicales libres hidrosolubles.It can be concluded, therefore, that the role antioxidant of iminoMAAs as such, that is, purified or isolated in a high degree of purity, it is not well known, nor is it its behavior at the level of free radical sequestration water soluble.
Un antioxidante se define como una sustancia que
en bajas concentraciones comparado con un substrato oxidable,
retrasa o previene su oxidación. La presente invención describe la
potencialidad del MAA M-gly aislado de Lichina
pygmaea como secuestrador de radicales e inhibidor de la
peroxidación lipídica. En los ensayos realizados, el nuevo
antioxidante es comparado con otro antioxidante ya conocido, el
\alpha-tocoferol. El compuesto descrito podría
utilizarse en aplicaciones terapeúticas, y en aplicaciones no
médicas para la estabilización de compuestos susceptibles del
deterioro oxidativo, en la preservación de alimentos o productos
relacionados, y en complementos nutricionales, nutracéuticos,
alimentos funcionales o de parafarmacia por sus propiedades
antioxidantes para prevenir el estrés
oxidativo.An antioxidant is defined as a substance that in low concentrations compared to an oxidizable substrate, delays or prevents its oxidation. The present invention describes the potential of the M-gly MAA isolated from Lichina pygmaea as a radical scavenger and lipid peroxidation inhibitor. In the tests performed, the new antioxidant is compared with another known antioxidant, α-tocopherol. The described compound could be used in therapeutic applications, and in non-medical applications for the stabilization of compounds susceptible to oxidative deterioration, in the preservation of food or related products, and in nutritional, nutraceutical, functional foods or parapharmacy supplements for their antioxidant properties for prevent stress
oxidative
La presente invención presenta un compuesto aislado de Lichina pygmaea con la siguiente estructura y de utilidad como antioxidante y secuestrador de radicales libres.The present invention presents an isolated compound of Lichina pygmaea with the following structure and useful as an antioxidant and free radical sequestrant.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Se han purificado compuestos del tipo aminoácidos tipo micosporina en fase acuosa partiendo de Lichyna pygmaea. Los compuestos se han detectado y caracterizado por HPLC. Se empleó un detector UV-visible (detector de fotodiodos 996), que medía la absorbancia para cada muestra entre los 290 y 400 nm. Una vez extraído el cromatograma a 330 nm, se identificaron los picos por co-cromatografía según sus espectros y tiempos de retención, comparándose con estándares de MAAs.Compounds of the mycosporin type amino acid type have been purified in the aqueous phase starting from Lichyna pygmaea . The compounds have been detected and characterized by HPLC. A UV-visible detector (photodiode detector 996) was used, which measured the absorbance for each sample between 290 and 400 nm. Once the chromatogram was extracted at 330 nm, the peaks were identified by co-chromatography according to their spectra and retention times, compared to MAAs standards.
La extracción a escala preparativa se realizó disolviendo 60-80 g (PF) de material biológico en l litro de metanol al 20% v/v e incubándose en un baño termostático a 45°C durante 2 horas. Posteriormente se centrifuga el extracto a 14000 rpm durante 15 min y rotavaporación a 45°C para eliminar parte del metanol de la muestra.Preparatory scale extraction was performed dissolving 60-80 g (PF) of biological material in l liter of 20% v / v methanol and incubating in a thermostatic bath to 45 ° C for 2 hours. Subsequently, the extract is centrifuged at 14000 rpm for 15 min and rotary evaporation at 45 ° C to eliminate part of the methanol in the sample.
La purificación se realizó en tres pasos consecutivos en los que se combinan técnicas cromatográficas de absorción mediante la aplicación de carbono activo, precipitación de polisacáridos al añadir a la muestra metanol 100% y separación final mediante cromatografía de intercambio iónico. Finalmente se obtuvieron soluciones acuosas de MAA en alto grado de pureza en concentraciones del orden de mM.The purification was done in three steps Consecutive in which chromatographic techniques of absorption by the application of active carbon, precipitation of polysaccharides by adding 100% methanol to the sample and separation final by ion exchange chromatography. Finally I know they obtained aqueous solutions of MAA in high degree of purity in concentrations of the order of mM.
Para medir la actividad como secuestrador de radicales hidrosolubles se ha utilizado el método de la ABTS peroxidasa, el cual permite determinar la actividad antioxidante total (TAA) de una muestra entendida como un parámetro que permite cuantificar la capacidad de una muestra, natural o procesada, de secuestrar radicales libres presentes en una solución acuosa.To measure activity as a hijacker of water-soluble radicals the ABTS method has been used peroxidase, which allows to determine the antioxidant activity total (TAA) of a sample understood as a parameter that allows quantify the capacity of a sample, natural or processed, of sequester free radicals present in an aqueous solution.
M-gly aislado de Lichina pygmaea inhibe la producción de radicales libres hidrosolubles (ABTS^{+}). La capacidad de inhición de M-gly aislado de Lichina pygmaea es dependiente del pH del medio de reacción, alcanzando los mejores resultados a pH 8, al contrario que el ácido ascórbico, que pierde actividad al alcalinizarse el medio. M-gly aislado de Lichina pygmaea podría utilizarse como inhibidor de procesos oxidativos en medios básicos, complementando a otros antioxidantes que pierden efectividad a tal pH.M-gly isolated from Lichina pygmaea inhibits the production of water-soluble free radicals (ABTS +). The inhition capacity of M-gly isolated from Lichina pygmaea is dependent on the pH of the reaction medium, reaching the best results at pH 8, unlike ascorbic acid, which loses activity when the medium is alkalinized. M-gly isolated from Lichina pygmaea could be used as an inhibitor of oxidative processes in basic media, complementing other antioxidants that lose effectiveness at such pH.
M-gly aislado de Lichina pygmaea se estudió como inhibidor de la peroxidación lipídica in vitro mediante la técnica de decoloración del \beta-caroteno. El método de decoloración del \beta-caroteno es ampliamente utilizado para la determinación de la capacidad antioxidante de diversas sustancias en medio lipofílico, la mayoría de ellas extraídas de frutas, vegetales y demás productos destinados a consumo alimentario para poder determinar su mayor o menor grado de autoconservación en estado natural. En este ensayo, como control positivo se utilizó el \alpha-tocoferol (\alpha-TOC).M-gly isolated from Lichina pygmaea was studied as an inhibitor of lipid peroxidation in vitro using the β-carotene bleaching technique. The method of decolorization of β-carotene is widely used to determine the antioxidant capacity of various substances in lipophilic medium, most of them extracted from fruits, vegetables and other products intended for food consumption in order to determine their degree of self-preservation in a natural state. In this test, α-tocopherol (α-TOC) was used as a positive control.
M-gly aislado de Lichina pygmaea muestra actividad antioxidante baja a nivel de inhibición de la peroxidación lipídica. Se constituye, pues, como un antioxidante de actividad baja in vitro.M-gly isolated from Lichina pygmaea shows low antioxidant activity at the level of lipid peroxidation inhibition. It is thus constituted as a low activity antioxidant in vitro .
El protocolo que se llevó a cabo fue basado en Marklund & Marklund (1974, Eur. j. Biochem., 47: 469-474) con algunas modificaciones. Relaciones de dosis-respuesta para las MAAs objeto de estudio se determinaron a diferentes concentraciones.The protocol that was carried out was based on Marklund & Marklund (1974, Eur. J. Biochem., 47: 469-474) with some modifications. Relations of dose-response for the MAAs under study is determined at different concentrations.
M-gly aislado de Lichina pygmaea no inhibe la cinética de oxidación del pirogalol.M-gly isolated from Lichina pygmaea does not inhibit the oxidation kinetics of pyrogallol.
M-gly aislado de Lichina pygmaea, en extractos o preparados que lo contengan, podría utilizarse en preparados o formulaciones farmacéuticas para la prevención y el tratamiento terapéutico de enfermedades o afecciones relacionadas con los radicales libres hidrosolubles, en productos de parafarmacia, en alimentos funcionales, complementos nutricionales y preparados nutracéuticos, y en la industria alimentaria (aditivo).M-gly isolated from Lichina pygmaea , in extracts or preparations containing it, could be used in pharmaceutical preparations or formulations for the prevention and therapeutic treatment of diseases or conditions related to water-soluble free radicals, in parapharmacy products, in functional foods, nutritional supplements and nutraceutical preparations, and in the food industry (additive).
Figura 1. Área (%) de picos eluídos y concentraciones expresadas en mg g^{-1} PS de diferentes MAAs presentes en extractos metanólicos de las algas Porphyra leucosticta, Gymnogongrus devoniensis, Gelidium sesquipedale y del liquen Lichina pygmaea. Se observa la presencia de un tipo de MAA mayoritario en cada organismo (> 66%) junto con otras MAAs minoritarias y trazas de sustancias no identificadas.Figure 1. Area (%) of eluted peaks and concentrations expressed in mg g-1 PS of different MAAs present in methanolic extracts of the algae Porphyra leucosticta, Gymnogongrus devoniensis, Gelidium sesquipedale and lichen Lichina pygmaea . The presence of a type of majority MAA in each organism (> 66%) is observed together with other minor MAAs and traces of unidentified substances.
Figura 2. Cromatograma de un extracto acuoso de M-gly aislado de Lichyna pygmaea eluído de la columna cargada con resina DOWEX.Figure 2. Chromatogram of an aqueous extract of M-gly isolated from Lichyna pygmaea eluted from the column loaded with DOWEX resin.
Figura 3. Porcentaje de inhibición de la cinética de generación del radical ABTS^{+} por M-gly a distintos pH y a distintas concentraciones de ensayo. Se compara con L-ascórbico. Se observa que a medida que aumenta el pH del medio aumenta la efectividad de la molécula al contrario que el L-ascórbico.Figure 3. Percentage of inhibition of Generation kinetics of the ABTS + radical by M-gly at different pH and at different concentrations of testing. It is compared with L-ascorbic. It is noted that as the pH of the medium increases the effectiveness of the molecule unlike the L-ascorbic.
Figura 4. Tabla. Dosis (\muM) - respuesta de la actividad antioxidante (%) de M-gly aislado de Lichyna pygmaea con respecto a 10 \muM de \alpha-tocoferol por el método de decoloración del \beta-caroteno. Los valores representan los valores medios y desviación estándar de 3 experimentos.Figure 4. Table. Dose (µM) - antioxidant activity response (%) of M-gly isolated from Lichyna pygmaea with respect to 10 µM of α-tocopherol by the method of decolorization of β-carotene. The values represent the mean values and standard deviation of 3 experiments.
Se ha purificado compuestos del tipo aminoácidos tipo micosporina en fase acuosa partiendo de Lichina pygmaea. Los compuestos se han detectado y caracterizado por HPLC (Waters 600). La columna empleada para la separación de los MAAs en el HPLC fue una C_{8} (Sphereclone^{TM}, Phenomenex, Aschaffenburg, Alemania), empaquetada con micropartículas porosas de sílica de 5 mm de diámetro con superficie derivatizada con una cadena alifática de 8 átomos de carbono (octadecil silano). Su tamaño era de 250 x 4.6 mm. Se empleó una precolumna (Phenomenex, Aschaffenburg, Alemania) afín a la columna empleada. La fase móvil que se empleó fue metanol al 2.5% (v/v, calidad HPLC) más 0.1% de ácido acético (v/v) bombeada isocráticamente a una velocidad de flujo de 0.5 ml min^{-1}. Se empleó un detector UV-visible (detector de fotodiodos 996), que medía la absorbancia para cada muestra entre los 290 y 400 nm. En la figura 1 vienen recogidos los porcentajes en área de los picos cromatografiados de distintos extractos algales, algunos identificados como MAAs y otros desconocidos. El objetivo de la purificación fue aislar en fase acuosa el MAA mayoritario en Lichina pygmaea además de eliminar trazas y otro tipos de compuestos no identificados.Compounds of the mycosporin type amino acid type have been purified in the aqueous phase starting from Lichina pygmaea . The compounds have been detected and characterized by HPLC (Waters 600). The column used for the separation of the MAAs in the HPLC was a C 8 (Sphereclone?, Phenomenex, Aschaffenburg, Germany), packed with porous silica microparticles of 5 mm in diameter with surface derivatized with an aliphatic chain of 8 carbon atoms (octadecyl silane). Its size was 250 x 4.6 mm. A pre-column (Phenomenex, Aschaffenburg, Germany) related to the column used was used. The mobile phase used was 2.5% methanol (v / v, HPLC quality) plus 0.1% acetic acid (v / v) isocratically pumped at a flow rate of 0.5 ml min -1. A UV-visible detector (photodiode detector 996) was used, which measured the absorbance for each sample between 290 and 400 nm. Figure 1 shows the percentages in area of the chromatographed peaks of different algal extracts, some identified as MAAs and others unknown. The objective of the purification was to isolate in the aqueous phase the major MAA in Lichina pygmaea in addition to eliminating traces and other types of unidentified compounds.
Una vez extraído el cromatograma a 330 nm, se identificaron los picos por co-cromatografía según sus espectros y tiempos de retención, comparándose con estándares de MAAs, proporcionados por el profesor Dr. Ulf Karsten (Universidad de Rostock, Alemania) extraídos de distintos organismos marinos: Mastocarpus stellatus (shinorine), Porphyra yezoensis (porphyra-334), Bostrychia scorpioides (palythine), los ojos de la trucha del coral Plectropomus leopardus (asterine 330) y el liquen Lichina pygmaea recolectado en Francia (M-gly). El cromatograma de los extractos recogidos después del paso por la columna de intercambio iónico DOWEX50 se muestran en la figura 2. M-gly apareció en un alto grado de pureza, observándose la ausencia de compuestos desconocidos con picos de absorción entre los 320 - 330 nm.Once the chromatogram was extracted at 330 nm, the peaks were identified by co-chromatography according to their spectra and retention times, compared with MAA standards, provided by Professor Dr. Ulf Karsten (University of Rostock, Germany) extracted from different organisms Marine: Mastocarpus stellatus (shinorine), Porphyra yezoensis (porphyra-334), Bostrychia scorpioides (palythine), the eyes of the coral trout Plectropomus leopardus (asterine 330) and the lichen Lichina pygmaea collected in France (M-gly). The chromatogram of the extracts collected after passing through the DOWEX50 ion exchange column are shown in Figure 2. M-gly appeared in a high degree of purity, observing the absence of unknown compounds with absorption peaks between 320-330 nm .
La extracción a escala preparativa se realizó disolviendo 60-80 g (PF) de material biológico en 1 litro de metanol al 20% v/v e incubándose en un baño termostático a 45°C durante 2 horas. Posteriormente se centrifuga el extracto a 14000 rpm durante 15 min y rotavaporación a 45°C para eliminar parte del metanol de la muestra.Preparatory scale extraction was performed dissolving 60-80 g (PF) of biological material in 1 liter of 20% v / v methanol and incubating in a thermostatic bath to 45 ° C for 2 hours. Subsequently, the extract is centrifuged at 14000 rpm for 15 min and rotary evaporation at 45 ° C to eliminate part of the methanol in the sample.
La purificación se realiza en tres pasos consecutivos en los que se combinan técnicas cromatográficas de absorción mediante la aplicación de carbono activo, precipitación de polisacáridos al añadir a la muestra metanol 100% y separación final mediante cromatografa de intercambio iónico (resina Dowex 50 W x 8-100). Para la elución del aminoácido tipo micosporina M-gly se utilizó como eluyente agua bidestilada, con un pH ligeramente alcalino (7.2). Finalmente se obtuvieron soluciones acuosas de MAA en alto grado de pureza en concentraciones del orden de mM.The purification is done in three steps Consecutive in which chromatographic techniques of absorption by the application of active carbon, precipitation of polysaccharides by adding 100% methanol to the sample and separation final by ion exchange chromatography (Dowex 50 resin W x 8-100). For elution of the amino acid type Mycosporin M-gly was used as water eluent double-distilled, with a slightly alkaline pH (7.2). Finally I know they obtained aqueous solutions of MAA in high degree of purity in concentrations of the order of mM.
Para medir la actividad como secuestradores de radicales hidrosolubles se ha utilizado el método de la ABTS peroxidasa, el cual permite determinar la actividad antioxidante total (TAA) de una muestra entendida como un parámetro que permite cuantificar la capacidad de una muestra, natural o procesada, de secuestrar radicales libres presentes en una solución acuosa. Este parámetro está orientado a dar información de la actividad antioxidante que puede presentar una muestra concreta con independencia de las actividades parciales que puedan presentar cada uno de sus componentes o los efectos de sinergismo que pudiesen establecerse.To measure activity as kidnappers of water-soluble radicals the ABTS method has been used peroxidase, which allows to determine the antioxidant activity total (TAA) of a sample understood as a parameter that allows quantify the capacity of a sample, natural or processed, of sequester free radicals present in an aqueous solution. This parameter is oriented to give activity information antioxidant that can present a specific sample with independence of the partial activities that each one of its components or the effects of synergism that could settle.
El 2,2'-Azino-bis-(3-etil-benzotiazolina-6-ácido sulfónico) o ABTS es un compuesto que presenta gran estabilidad química, alta solubilidad en agua y un máximo de absorción en la banda del UVA a 342 nm. Este compuesto en presencia de H_{2}O_{2} y enzimas peroxidasas deriva a un radical metaestable (ABTS^{+}) con un espectro de absorción característico y diferente al ABTS, presentando máximos de absorción en la región espectral del UV y visible a 413, 645, 727 y 811 nm.He 2,2'-Azino-bis- (3-ethyl-benzothiazoline-6-acid sulfonic) or ABTS is a compound that has great stability chemical, high water solubility and maximum absorption in the UVA band at 342 nm. This compound in the presence of H 2 O 2 and peroxidases enzymes derive to a metastable radical (ABTS +) with a characteristic and different absorption spectrum to ABTS, presenting maximum absorption in the spectral region UV and visible at 413, 645, 727 and 811 nm.
El ABTS es un producto que presenta gran estabilidad en un amplio rango de pH, mostrando el mismo espectro de absorbancia a pH 4 y pH 8.5. Así mismo, la formación del radical ABTS^{+} también se lleva a cabo en ese rango de pH pero la actividad enzimática de la peroxidasa sí que es dependiente del pH del medio de reacción de manera que al alcalinizarse éste la actividad disminuye, aumentando así el periodo de retardo o "lag time". La actividad de nuestra enzima se podría ajustar a una curva exponencial de manera que es máxima a pH 4.5 y deja de ser activa a pH superiores a 10. Nuestros ensayos discurrirán a pH 6-8.5 de manera que aseguramos la actividad de la enzima.ABTS is a product that presents great stability over a wide pH range, showing the same spectrum of absorbance at pH 4 and pH 8.5. Likewise, the formation of the radical ABTS + is also carried out in that pH range but the enzymatic activity of peroxidase itself that is pH dependent of the reaction medium so that upon alkalization it the activity decreases, thus increasing the delay period or "lag time ". The activity of our enzyme could be adjusted to a exponential curve so that it is maximum at pH 4.5 and ceases to be active at pH higher than 10. Our tests will run at pH 6-8.5 so that we ensure the activity of the enzyme.
La cuantificación de la capacidad de secuestro de radicales libres de una muestra se llevan a cabo mediante ensayos de decoloración en los cuales la formación de ABTS^{+} da lugar a una coloración característica que disminuirá de manera proporcional a la cantidad de sustancias con capacidad de atrapar estos radicales que se le añadan al volumen de reacción. Esta pérdida de color puede medirse mediante seguimientos cinéticos de pérdida de absorbancia a 413 nm (longitud de onda que no interfiere con otras moléculas) a lo largo de un minuto utilizando como peroxidasa la HRP y como control negativo el ácido ascórbico (L-ASC). El medio de reacción se compone de tampón fosfato 50 mM pH 6, 7.5, 8, H_{2}O_{2} 2 mM, ABTS 2 mM, enzima HRP 0.25 \muM y muestra a concentraciones crecientes.The quantification of kidnapping capacity Free radicals of a sample are carried out by bleaching assays in which the formation of ABTS + gives place to a characteristic coloration that will decrease so proportional to the amount of substances capable of trapping these radicals that are added to the reaction volume. This Color loss can be measured by kinetic tracking of loss of absorbance at 413 nm (wavelength that does not interfere with other molecules) over a minute using as peroxidase HRP and as a negative control ascorbic acid (THE C). The reaction medium is composed of buffer 50 mM phosphate pH 6, 7.5, 8, 2 mM H2O2, 2 mM ABTS, enzyme 0.25 µM HRP and sample at increasing concentrations.
El cálculo de TAA se establece según la relación entre las pendientes (Abs/min) de ensayos enzimáticos en los cuales el curso de la reacción es estimado en ausencia de antioxidantes (control positivo), y en presencia de diferentes concentraciones de sustancias con posible actividad antioxidante. De este modo, la pendiente de la cinética control correspondería a una TAA del cero por ciento,
\hbox{calculándose en base a ésta los porcentajes de inhibición de las demás curvas.}The calculation of TAA is established according to the relationship between the slopes (Abs / min) of enzymatic tests in which the course of the reaction is estimated in the absence of antioxidants (positive control), and in the presence of different concentrations of substances with possible activity antioxidant Thus, the slope of the kinetic control would correspond to a TAA of zero percent,
\ hbox {calculating based on this the percentages of inhibition of the other curves.}
La peroxidación lipídica es un mecanismo bien establecido de daño celular en plantas y animales, así como de deterioro de alimentos (enranciamiento). Este proceso conduce a la producción de peróxidos lipídicos y aldehídos de degradación que conlleva pérdida de la función de la membrana celular y de su integridad. M-gly aislado de Lichina pygmaea se estudió como inhibidor de la peroxidación lipídica in vitro mediante la técnica de decoloración del \beta-caroteno.Lipid peroxidation is a well-established mechanism of cell damage in plants and animals, as well as food spoilage (thickening). This process leads to the production of lipid peroxides and degradation aldehydes that leads to loss of cell membrane function and integrity. M-gly isolated from Lichina pygmaea was studied as an inhibitor of lipid peroxidation in vitro using the β-carotene bleaching technique.
El método de decoloración del \beta-caroteno es ampliamente utilizado para la determinación de la capacidad antioxidante de diversas sustancias en medio lipofílico, la mayoría de ellas extraídas de frutas, vegetales y demás productos destinados a consumo alimentario para poder determinar su mayor o menor grado de autoconservación en estado natural. Se trata de un método espectrofotométrico que mide la inhibición que causa un antioxidante sobre la decoloración del \beta-caroteno en un sistema acuoso emulsificado con Tween 20 y ácido linoleico.The method of fading β-carotene is widely used for determination of the antioxidant capacity of various substances in lipophilic medium, most of them extracted from fruits, vegetables and other products intended for food consumption for be able to determine its greater or lesser degree of self-preservation in natural state. It is a spectrophotometric method that measures the inhibition that an antioxidant causes on the discoloration of the β-carotene in an emulsified aqueous system with Tween 20 and linoleic acid.
El ácido linoleico se autoxida a una alta velocidad ante la presencia de átomos de hidrógeno especialmente activados. El \beta-caroteno, precursor de la vitamina A, también es conocido como antioxidante lipofílico que previene de la peroxidación lipídica en membranas secuestrando moléculas de oxígeno singlete y radicales lipídicos peroxilos. El \beta-caroteno, cuando se encuentra en presencia de ácido linoleico, cede electrones retardando la etapa de iniciación del proceso de autooxidación del ácido linoleico así como limitando la fase de propagación del daño al eliminar simultáneamente radicales peróxidos formados. Si añadimos una nueva sustancia con posible capacidad antioxidante al medio de reacción que contiene ácido linoleico y \beta-caroteno, ésta nueva sustancia tenderá a oxidarse ella preferentemente al \beta-caroteno, compitiendo con este por el secuestro de estos radicales.Linoleic acid self-oxidizes at high velocity in the presence of hydrogen atoms especially activated Β-carotene, precursor of the Vitamin A, is also known as lipophilic antioxidant that prevents lipid peroxidation in sequestering membranes singlet oxygen molecules and peroxyl lipid radicals. He β-carotene, when in presence of linoleic acid, yields electrons delaying the stage of initiation of the linoleic acid autooxidation process as well as limiting the propagation phase of damage by eliminating simultaneously formed peroxide radicals. If we add a new one substance with possible antioxidant capacity to the reaction medium which contains linoleic acid and β-carotene, this new substance will tend to oxidize it preferably at β-carotene, competing with this for the kidnapping of these radicals.
El \beta-caroteno presenta un máximo de absorción a 470 nm. Este máximo varía cuando la molécula se oxida ya que pierde dobles enlaces y la estructura del cromóforo de la molécula se ve alterada, perdiendo así su característico color naranja y pudiendo ser detectado espectrofotométricamente. La absorbancia del medio de reacción permanecerá invariable a lo largo del tiempo en presencia de sustancias antioxidantes, advirtiéndose una caída en la absorbancia de la muestra cuando se mida en ausencia de antioxidantes. Así pues, la medida de la capacidad antioxidante de una sustancia será inversamente proporcional a la caída de pendiente de la curva que describe la oxidación del \beta-caroteno (medida a longitud de onda de 470 nm).Β-carotene has a maximum absorption at 470 nm. This maximum varies when the molecule it oxidizes because it loses double bonds and the chromophore structure of the molecule is altered, thus losing its characteristic Orange color and can be detected spectrophotometrically. The absorbance of the reaction medium will remain unchanged throughout of time in the presence of antioxidant substances, warning a drop in the absorbance of the sample when measured in absence of antioxidants So, the measure of capacity Antioxidant of a substance will be inversely proportional to the slope slope of the curve describing the oxidation of the β-carotene (measured at 470 wavelength nm).
En este ensayo, como control positivo se utilizó el \alpha-tocoferol (\alpha-TOC).In this trial, a positive control was used the α-tocopherol (α-TOC).
La actividad de la solución se evaluó según el grado de decoloración del \beta-caroteno, aplicando la fórmula propuesta por Hidalgo y colaboradores (1994, Phytochemistry, 37: 158-1587) con algunas modificaciones:The activity of the solution was evaluated according to the degree of discoloration of β-carotene, applying the formula proposed by Hidalgo et al. (1994, Phytochemistry, 37: 158-1587) with some modifications:
AA = [P\ muestra - P\ control / P\ Patrón - P\ control] \cdot 100AA = [P \ Sample - P \ control / P \ Pattern - P \ control] \ cdot 100
P hace referencia a las pendientes de las curvas de decoloración obtenidas (Abs/tiempo). Para ello ajustamos mediante regresión lineal la parte de la curva cinética que describe un comportamiento lineal. Los coeficientes de correlación para cada réplica de cada muestra eran todos superiores a 0.98.P refers to the slopes of the curves of discoloration obtained (Abs / time). For this we adjust by linear regression the part of the kinetic curve that describes a linear behavior The correlation coefficients for each Replica of each sample were all greater than 0.98.
Los radicales superóxidos (O_{2}^{-}) son mediadores de reacciones de autooxidación de algunos compuestos. La mayoría de las veces estos compuestos oxidados se caracterizan por poseer un espectro de absorción característico y cuantificable por espectrofotometría.The superoxide radicals (O2 -) are mediators of autooxidation reactions of some compounds. The most of the time these oxidized compounds are characterized by have a characteristic and quantifiable absorption spectrum by spectrophotometry
El pirogalol (1,2,3-benzenotriol) es una sustancia que se autooxida rápidamente en presencia de oxígeno especialmente en soluciones alcalinas. A pH 7.9 la SOD inhibe el 99% de la reacción indicando una participación prácticamente total del anión superóxido O_{2}^{-} en la reacción. El pirogalol oxidado presenta un máximo de absorción a 420 nm de manera que la capacidad de las MAAs para secuestrar radicales superóxido fue medida como pérdida de absorbancia de ensayos cinéticos monitorizados espectrofotométricamente (Shimadzu UV 1603) durante un minuto de reacción. El protocolo que se llevó a cabo fue basado en Marklund & Marklund (1974, Eur. j. Biochem., 47: 469-474) con algunas modificaciones. La mezcla reacción contenía 0.4 mM de pirogalol y el MAA a diferentes concentraciones en 50 mM de tampón fosfato a pH 8.2, conteniendo 1 mM de ácido dietilenotriaminopentaacético en un volumen final de incubación de 1 ml. La temperatura se mantuvo estable a 20 \pm 1°C. El control positivo fue la curva cinética de generación de radicales de pirogalol oxidado en ausencia de antioxidantes para compararlos con distintas concentraciones de SOD como antioxidante conocido. Relaciones de dosis-respuesta para las MAAs objeto de estudio se determinaron a diferentes concentraciones. La capacidad de secuestro de radicales superóxido de los extractos purificados se evaluó siguiendo la siguiente fórmula:Pyrogallol (1,2,3-benzenotriol) is a substance that is autooxidizes rapidly in the presence of oxygen especially in alkaline solutions At pH 7.9 SOD inhibits 99% of the reaction indicating a practically total participation of the superoxide anion O 2 - in the reaction. Oxidized pyrogallol has a maximum absorption at 420 nm so that the capacity of the MAAs to sequester superoxide radicals was measured as loss of absorbance of monitored kinetic assays spectrophotometrically (Shimadzu UV 1603) for one minute of reaction. The protocol that was carried out was based on Marklund & Marklund (1974, Eur. J. Biochem., 47: 469-474) with some modifications. Mix reaction contained 0.4 mM pyrogallol and MAA at different 50 mM concentrations of phosphate buffer at pH 8.2, containing 1 mM of diethylenetriaminepentaacetic acid in a final volume of 1 ml incubation. The temperature was stable at 20 ± 1 ° C The positive control was the kinetic curve of generating oxidized pyrogallol radicals in the absence of antioxidants for compare them with different concentrations of SOD as an antioxidant known. Dose-response relationships for MAAs under study were determined at different concentrations. The ability to sequester superoxide radicals from extracts Purified was evaluated following the following formula:
AA = 100 - [P\ muestra \cdot 100/ P\ control]AA = 100 - [P \ sample \ cdot 100 / P \ control]
P hace referencia a las pendientes de las curvas cinéticas de oxidación del pirogalol (Abs/tiempo).P refers to the slopes of the curves oxidation kinetics of pyrogallol (Abs / time).
Claims (3)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200702954A ES2301438B1 (en) | 2005-08-31 | 2005-08-31 | USE OF MICOSPORINE TYPE AMINO ACID (M-GLY) IN THE PREVENTION OF OXIDATION OF COSMETIC AND PHARMACEUTICAL PRODUCTS. |
ES200502162A ES2301294B1 (en) | 2005-08-31 | 2005-08-31 | USE OF MICOSPORINE TYPE AMINO ACID (M-GLY) IN PRODUCTS FOR PREVENTION AND TREATMENT OF ACTINIC ERYTHEMA, PHOTOCARCINOGENESIS AND PHOTO AGING. |
ES200702955A ES2301439B1 (en) | 2005-08-31 | 2005-08-31 | USE OF MICOSPORINE TYPE AMINO ACID (M-GLY) AS AN ANTIOXIDANT OR ADDITIVE IN FOOD PRODUCTS. |
PCT/ES2006/000489 WO2007026036A2 (en) | 2005-08-31 | 2006-08-28 | Use of a mycosporin-type amino acid (m-gly) as an antioxidant |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200502162A ES2301294B1 (en) | 2005-08-31 | 2005-08-31 | USE OF MICOSPORINE TYPE AMINO ACID (M-GLY) IN PRODUCTS FOR PREVENTION AND TREATMENT OF ACTINIC ERYTHEMA, PHOTOCARCINOGENESIS AND PHOTO AGING. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2301294A1 true ES2301294A1 (en) | 2008-06-16 |
ES2301294B1 ES2301294B1 (en) | 2009-05-01 |
Family
ID=37809230
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES200502162A Active ES2301294B1 (en) | 2005-08-31 | 2005-08-31 | USE OF MICOSPORINE TYPE AMINO ACID (M-GLY) IN PRODUCTS FOR PREVENTION AND TREATMENT OF ACTINIC ERYTHEMA, PHOTOCARCINOGENESIS AND PHOTO AGING. |
ES200702955A Active ES2301439B1 (en) | 2005-08-31 | 2005-08-31 | USE OF MICOSPORINE TYPE AMINO ACID (M-GLY) AS AN ANTIOXIDANT OR ADDITIVE IN FOOD PRODUCTS. |
ES200702954A Active ES2301438B1 (en) | 2005-08-31 | 2005-08-31 | USE OF MICOSPORINE TYPE AMINO ACID (M-GLY) IN THE PREVENTION OF OXIDATION OF COSMETIC AND PHARMACEUTICAL PRODUCTS. |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES200702955A Active ES2301439B1 (en) | 2005-08-31 | 2005-08-31 | USE OF MICOSPORINE TYPE AMINO ACID (M-GLY) AS AN ANTIOXIDANT OR ADDITIVE IN FOOD PRODUCTS. |
ES200702954A Active ES2301438B1 (en) | 2005-08-31 | 2005-08-31 | USE OF MICOSPORINE TYPE AMINO ACID (M-GLY) IN THE PREVENTION OF OXIDATION OF COSMETIC AND PHARMACEUTICAL PRODUCTS. |
Country Status (2)
Country | Link |
---|---|
ES (3) | ES2301294B1 (en) |
WO (1) | WO2007026036A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2317741A1 (en) * | 2006-06-20 | 2009-04-16 | Universidad De Malaga | Composition for solar protection based on algae and liquenes extracts. (Machine-translation by Google Translate, not legally binding) |
CN109260045A (en) * | 2018-10-17 | 2019-01-25 | 拉芳家化股份有限公司 | A kind of spore of bacterium containing class element-glycine from anti-corrosion moisturizing essence |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2054483T3 (en) * | 1989-12-01 | 1994-08-01 | Astra Ab | IMPROVED METHOD FOR PREPARING AN INTERMEDIATE PRODUCT FOR THE MANUFACTURE OF BAMBUTEROL. |
FR2803201A1 (en) * | 1999-12-30 | 2001-07-06 | Gelyma | Algal extracts containing amino acid analogs of mycosporin are useful as dermatological protecting agents against ultraviolet radiation |
WO2002039974A1 (en) * | 2000-11-17 | 2002-05-23 | Natural Environment Research Council | Personal care compositions |
US6787147B1 (en) * | 1998-10-23 | 2004-09-07 | Norman Huner | Solar radiation protection composition |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2655268B1 (en) * | 1989-12-06 | 1994-10-14 | Secma | USE OF ALGAE EXTRACTS FOR THE PREPARATION OF PHARMACEUTICAL, COSMETIC, FOOD OR AGRICULTURAL COMPOSITIONS. |
FR2832629B1 (en) * | 2001-11-14 | 2006-05-19 | Larena | A PRODUCT CONTAINING A RED ALGAE EXTRACT OF THE PORPHYRA GENUS AND ITS USES FOR PROTECTING CELLS |
-
2005
- 2005-08-31 ES ES200502162A patent/ES2301294B1/en active Active
- 2005-08-31 ES ES200702955A patent/ES2301439B1/en active Active
- 2005-08-31 ES ES200702954A patent/ES2301438B1/en active Active
-
2006
- 2006-08-28 WO PCT/ES2006/000489 patent/WO2007026036A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2054483T3 (en) * | 1989-12-01 | 1994-08-01 | Astra Ab | IMPROVED METHOD FOR PREPARING AN INTERMEDIATE PRODUCT FOR THE MANUFACTURE OF BAMBUTEROL. |
US6787147B1 (en) * | 1998-10-23 | 2004-09-07 | Norman Huner | Solar radiation protection composition |
FR2803201A1 (en) * | 1999-12-30 | 2001-07-06 | Gelyma | Algal extracts containing amino acid analogs of mycosporin are useful as dermatological protecting agents against ultraviolet radiation |
WO2002039974A1 (en) * | 2000-11-17 | 2002-05-23 | Natural Environment Research Council | Personal care compositions |
Non-Patent Citations (2)
Title |
---|
DUNLAP, W.C. y YAMAMOTO, Y. Small-molecule antioxidants in marine organisms: antioxidant activity of mycosporine-glycine. Comp. Biochem.Physiol, 1995, vol. 112B (1), páginas 105-114. * |
GRÖNIGER et al. Photoprotective compounds in cyanobacteria, phytoplancton and macroalgae- a database. Journal of Phytochemistry and Photobiology B. Biology, 2000, vol. 58, páginas 115-122. * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2317741A1 (en) * | 2006-06-20 | 2009-04-16 | Universidad De Malaga | Composition for solar protection based on algae and liquenes extracts. (Machine-translation by Google Translate, not legally binding) |
CN109260045A (en) * | 2018-10-17 | 2019-01-25 | 拉芳家化股份有限公司 | A kind of spore of bacterium containing class element-glycine from anti-corrosion moisturizing essence |
Also Published As
Publication number | Publication date |
---|---|
WO2007026036A2 (en) | 2007-03-08 |
ES2301439A1 (en) | 2008-06-16 |
ES2301438B1 (en) | 2009-05-01 |
ES2301438A1 (en) | 2008-06-16 |
ES2301294B1 (en) | 2009-05-01 |
ES2301439B1 (en) | 2009-05-01 |
WO2007026036A3 (en) | 2007-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
De la Coba et al. | Antioxidant activity of mycosporine-like amino acids isolated from three red macroalgae and one marine lichen | |
Shiuan et al. | Effects of Clinacanthus nutans (Burm. f) Lindau leaf extracts on protection of plasmid DNA from riboflavin photoreaction | |
Mandade et al. | Radical scavenging and antioxidant activity of Carthamus tinctorius extracts | |
Zhao et al. | In-vitro free radical scavenging activities of anthocyanins from three berries | |
Vinayagam et al. | Antioxidant activity of methanolic extracts of leaves and flowers of Nerium indicum | |
Lee et al. | Antioxidant properties of tidal pool microalgae, Halochlorococcum porphyrae and Oltamannsiellopsis unicellularis from Jeju Island, Korea | |
ES2301294B1 (en) | USE OF MICOSPORINE TYPE AMINO ACID (M-GLY) IN PRODUCTS FOR PREVENTION AND TREATMENT OF ACTINIC ERYTHEMA, PHOTOCARCINOGENESIS AND PHOTO AGING. | |
ES2301434B1 (en) | USE OF AMINO ACID TYPE MICOSPORINE (PORFINE 334) IN PRODUCTS FOR PREVENTION OF CATARATES. | |
ES2284344B1 (en) | USE OF AMINO ACID TYPE MICOSPORINE (SHIMORINE) IN PRODUCTS FOR PREVENTION AND TREATMENT OF PARKINSON AND ALZHEIMER. | |
ES2303412B1 (en) | USE OF A PURIFIED MIXTURE OF MICOSPORINE TYPE AMINO ACIDS (ASTERINE 330 + PALITINE) IN PRODUCTS FOR THE PREVENTION OF CANCERIGENE PROCESSES. | |
Seo et al. | Antioxidant and Xanthine Oxidase Inhibition Activities of Cynomorium songaricum Extracts | |
KR20120108139A (en) | Compositions for antioxidation comprising extract of agarum clathratum |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 20080616 Kind code of ref document: A1 |